Edition:
United Kingdom

People: Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.74USD
9:02pm BST
Change (% chg)

$-0.11 (-0.26%)
Prev Close
$42.85
Open
$43.11
Day's High
$43.19
Day's Low
$42.73
Volume
3,883,404
Avg. Vol
6,633,958
52-wk High
$46.46
52-wk Low
$37.12

Mackenzie, Alexander 

Dr. Alexander R. Mackenzie is the Executive Vice President, Chief Development Officer of the company. He was Senior Vice President, Chief Development Officer from March 2016 until June 2016. Group Senior Vice President and Head, Pharma Therapeutics Research and Development from 2010 until March 2016. Senior Vice President, Head of Worldwide Research from 2007 until 2010. Dr. MacKenzie represents Pfizer as a member of the Board of Directors of ViiV Healthcare Limited.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

19,549,200

Albert Bourla

9,854,560

Frank D'Amelio

7,139,830

Mikael Dolsten

7,070,200

Michael Goettler

--

Angela Hwang

--
As Of  31 Dec 2018